Santa Cruz Biotechnology offers a broad range of CCDC180 Antibodies for research focused on understanding CCDC180 protein functions. CCDC180 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CCDC180, or Coiled-Coil Domain Containing 180, plays essential roles in cellular processes such as cell division and cytoskeletal organization. CCDC180 maintains cellular integrity and facilitates communication between cells. Research has shown that CCDC180 dysregulation is linked to various diseases, highlighting its significance in cell biology and pathology. Understanding CCDC180's molecular mechanisms and cellular functions can provide critical insights into disease development and progression. Investigating CCDC180's role in different cellular pathways may reveal new therapeutic targets. Current research continues to uncover novel functions and regulatory mechanisms of CCDC180 in health and disease. Santa Cruz Biotechnology monoclonal antibodies for CCDC180 enable researchers worldwide to advance scientific understanding and potentially develop new therapeutic strategies.